Skip to main content

Vitiligo (Immunology) — Deal Benchmarks & Valuation

Median Upfront
$548M
Range: $291M - $793M
Total Deal Value
$2.9B
Range: $1.8B - $3.9B
Royalty Rate
13.8% - 23%
Tiered up to 27%
Dev Milestones
$461M
Range: $296M - $629M
Model Your Deal

Market Analysis

Vitiligo (Immunology) is one of the most actively transacted indications in immunology licensing. Phase 2 deals for vitiligo (immunology) carry a median total deal value of $2.9B, with upfront payments ranging from $291M to $793M. The recommended deal structure allocates approximately 19% to upfront payments and 81% to milestones.

Milestone structures for vitiligo (immunology) deals allocate $461M to development milestones, $807M to regulatory milestones, and $1.0B to commercial milestones. Royalty rates range from 13.8% to 23% at the base tier, with tiered escalation reaching 17.8%-27% on peak sales.

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

What are typical deal terms for vitiligo (immunology) licensing?
Phase 2 vitiligo (immunology) licensing deals average $548M in upfront payments with $2.9B total deal value. The 19/81 upfront/milestone split reflects the risk profile at this clinical stage.
What royalty rates are standard for vitiligo (immunology) deals?
Base royalty rates for vitiligo (immunology) transactions range from 13.8% to 23%, with tiered escalations reaching 17.8%-27% on peak sales. Rates are influenced by mechanism differentiation, competitive positioning, and territorial scope.
How are vitiligo (immunology) deal milestones structured?
Vitiligo (Immunology) deals allocate approximately 81% of total deal value to milestones. Development milestones ($461M) make up the largest share, followed by commercial milestones ($1.0B) and regulatory milestones ($807M).
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Related Benchmarks

Rheumatoid Arthritis Deals

View

Systemic Lupus (SLE) Deals

View

Lupus Nephritis Deals

View

Immunology Deal Overview

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.

Start Calculating
For Funds & Advisors

Need the full deal landscape?

The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.

Configure Brief — $2,500All-inclusive · White-label · Walkthrough included